2020
DOI: 10.1111/ecc.13235
|View full text |Cite
|
Sign up to set email alerts
|

Socio‐economic and occupational outcomes of long‐term survivors of gynaecological cancer: A French population‐based study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…In a study of clinical predictors of RTW by cancer type, gynecological cancer patients receiving radiotherapy reported more stiffness in joints and muscles, localized swelling and skin soreness in the affected area than did breast cancer patients ( Cooper et al, 2013 ). Such patients with impaired physical wellbeing may be more likely to report in reduced work hours ( Mamguem Kamga et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…In a study of clinical predictors of RTW by cancer type, gynecological cancer patients receiving radiotherapy reported more stiffness in joints and muscles, localized swelling and skin soreness in the affected area than did breast cancer patients ( Cooper et al, 2013 ). Such patients with impaired physical wellbeing may be more likely to report in reduced work hours ( Mamguem Kamga et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…With screening programs for the early detection of cancer and improvements in cancer treatment, the number of working-age cancer survivors has increased. Several studies have addressed the impact of returning to work on cancer survivors, such as changes in working ability [25], income [26], and quality of life [27][28][29]. However, our study is the first to analyze the survival outcome in cervical cancer survivors after returning to work.…”
Section: Discussionmentioning
confidence: 99%
“…In 2018, the European organization “Youth Cancer Europe” named financial discrimination as one of the five key challenges needed to be addressed on a national and European policy level [ 16 ]. More and more studies show that CCS are excluded from mortgages and private insurances such as life insurance, supplementary health insurance or travel insurance [ 16 , 56 – 58 ]. This results in many CCS being discriminated against (as recipients of unequal treatment) either via denied insurance or by having to pay higher premiums than people without chronic health-conditions [ 58 ].…”
Section: Discussionmentioning
confidence: 99%